Objective        To analyze the relationship of hyposexuality (HS) with the symptoms of chronic prostatitis (CP) and the psychological factors in patients with CP.       Methods        From September 2013 to November 2014

a total of 103 outpatients with CP

aged of 20-50

were consecutively enrolled in this study. Anonymous questionnaires were used to investigate the scores of the national institute of the health chronic prostatitis symptom index (NIH-CPSI)

self-rating anxiety scale (SAS) and a symptom score system devised for patients with erectile dysfunction (O’Leary 1995). According to HS state

the patients were divided into an observation group and a control group

and the anxiety scores and inflammation state of the prostate gland were analyzed. The observation group was subdivided into group A and group B. Group A was treated with tamsulosin hydrochloride sustained-release tablets + prostate bolt + prostate massage + life intervention + psychological therapy

and group B was treated with tamsulosin hydrochloride sustained-release tablets + prostate bolt + prostate massage + life intervention. In the observation group

the patients with severe symptoms and prostate fluid leukocyte counts+++/HP were prescribed with antibiotics. The questionnaires were rewritten after 8 weeks of treatments

and the scores of the two groups were compared.       Results        About 57.3% of CP patients accompanied with anxiety and about 43.7% accompanied with HS. There was positive correlation between CPSI score and SAS score (r=0.92

P0.05). HS evaluation was correlated with CPSI evaluation (r=0.69

P0.05)

and was negatively with SAS evaluation (r=-0.73

P0.05). CPSI score and SAS score in the observation group were obviously higher than those in the control group. After treatment

the prostate gland inflammation state

anxiety symptoms

and the loss of libido in group A were alleviated

and the difference was statistically significant (P0.05). In group B

the prostate gland inflammation state was alleviated after treatment

with statistically significant difference (P0.05)

however

the anxiety symptoms and loss of libido had no statistically significant difference (P0.05).       Conclusion        CP patients with HS are frequently accompanied with more psychological obstacles. The heavier the CP symptoms are

the more noticeable the HS and psychological obstacles are. In order to improve the life quality of the patients

more attention must be paid to the psychological counseling besides conventional drugs and physical therapy in the treatment process.